Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
    8.
    发明授权
    Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives 有权
    NH-酸性化合物的前药:酯,碳酸盐,氨基甲酸酯和膦酸酯衍生物

    公开(公告)号:US09585965B2

    公开(公告)日:2017-03-07

    申请号:US14719396

    申请日:2015-05-22

    摘要: The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.

    摘要翻译: 本发明提供了一种通过向患者施用有效量的本发明的前药化合物来持续递送内酰胺,酰亚胺,酰胺,磺酰胺,氨基甲酸酯或含尿素的母体药物的方法,其中在给予患者时释放母体 来自前药的药物是持续释放的。 适用于本发明方法的前药化合物是通过羰基连接的前药部分衍生化的母体药物的不稳定偶联物。 本发明的前体药物化合物可用于治疗内酰胺,酰胺,酰胺,磺酰胺,氨基甲酸酯或含有母体药物的尿素作为治疗的任何条件。

    Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
    9.
    发明授权
    Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives 有权
    NH-酸性化合物的前药:酯,碳酸盐,氨基甲酸酯和膦酸酯衍生物

    公开(公告)号:US09072788B2

    公开(公告)日:2015-07-07

    申请号:US14034918

    申请日:2013-09-24

    摘要: The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.

    摘要翻译: 本发明提供了一种通过向患者施用有效量的本发明的前药化合物来持续递送内酰胺,酰亚胺,酰胺,磺酰胺,氨基甲酸酯或含尿素的母体药物的方法,其中在给予患者时释放母体 来自前药的药物是持续释放的。 适用于本发明方法的前药化合物是通过羰基连接的前药部分衍生化的母体药物的不稳定偶联物。 本发明的前体药物化合物可用于治疗内酰胺,酰胺,酰胺,磺酰胺,氨基甲酸酯或含有母体药物的尿素作为治疗的任何条件。